Shaking the MoneyTree
|
|
- Egbert McCormick
- 5 years ago
- Views:
Transcription
1 Hosted by: Shaking the MoneyTree pwc
2 Agenda Please join PricewaterhouseCoopers, Cooley Godward Kronish LLP and a distinguished panel as they provide insight into Venture Investments, including PwC's Shaking the MoneyTree Report. MoneyTree Thursday, September 3, 2009 Wilson Sonsini Goodrich & Rosati 650 Page Mill Road Palo Alto, California :00-7:00 p.m. Registration and Networking 7:00-8:15 p.m. Presentation and Panel Discussion Moderator Steve Bengston, PricewaterhouseCoopers LLP Event Panelists Tim Carey, PricewaterhouseCoopers LLP Emmett Cunningham, Clarus Ventures Rich Ferrari, De Novo Ventures Allan May, Emergent Medical Parnters Rich Redelfs, Foundation Capital PricewaterhouseCoopers/National Venture Capital Association MoneyTree TM Report based on data from Thomson Reuters. PricewaterhouseCoopers 1
3 Event Panelists PricewaterhouseCoopers 2
4 Steve Bengston Director PricewaterhouseCoopers LLP Steve is Director of Emerging Company Services (ECS) at PricewaterhouseCoopers. ECS acts as mentor capitalists for young, high potential companies and assists them with a variety of services, including, Review- ing Executive Summaries/Investor Presentations, Referrals, Raising Money, Partnerships and Finding People. Before joining PwC, Steve had 20 years of experience in a variety of marketing, business development and general management roles at several high tech companies in the Bay Area. Most recently, he was Pres/ CEO of ynot.com, a leading international emarketing and greeting card company. Previously, he was VP Marketing & Business Development at Worldview Systems, an Internet travel pioneer. At Worldview, Steve helped launch and market Travelocity with Sabre Interactive. Steve has a BA in Economics and MBA from Stanford University. He works closely or sits on the Advisory Board at Churchill Club, SVASE, SDForum, Life Science Angels, Entrepreneurs Foundation, and the Stanford/MIT Venture Lab, has taught classes on start ups at UC Berkeley, Santa Clara Law School, Hastings Law School, and Stanford, and is active in a variety of other organizations in the Bay Area targeting entrepreneurs and investors. He also hosts the PricewaterhouseCoopers Startup radio show at He is a frequent moderator/panelist at both university and industry sponsored events. PricewaterhouseCoopers 3
5 Tim Carey Partner PricewaterhouseCoopers LLP Tim Carey joined PricewaterhouseCoopers' Detroit office in 1992 and was admitted to the partnership in He has spent the past 7 years as a Partner in the San Jose office specializing in the semiconductor industry. Tim also spent two years in our Manchester, England office and has extensive experience working in both Europe and Asia. Tim is the US Leader of the firm's CleanTech practice and has worked with numerous companies in the renewable energy and transportation sectors within CleanTech. He is the firm's liaison to VC CleanTech funds and is responsible for PwC's thought leadership efforts within the sector. Tim has extensive SEC experience having served as the lead Engagement Partner on five IPO's and numerous debt and equity offerings. In addition, he has significant experience with M&A transactions ranging from acquisitions, spin-offs and divestitures to complex joint ventures, strategic investments and alliances. In addition to client work, Tim speaks regularly to outside groups on a variety of topics including corporate governance, revenue recognition, accounting for stockbased compensation and initial public offerings. He is also currently on the board of the Silicon Valley Chapter of the National Association of Corporate Directors. Tim received a Bachelor s degree in Financial Administration from Michigan State University in 1987 and an MBA with Distinction from the University of Michigan in He is a certified public accountant and a member of the American Institute of Certified Public Accountants as well as the Michigan and California Associations of Certified Public Accountants. Tim is also a Board Member of the Silicon Valley Chapter of the National Association of Corporate Directors and is affiliated with the American Institute of Certified Public Accountants, California Society of Certified Public Accountant and Michigan Association of Certified Public Accountants. PricewaterhouseCoopers 4
6 Emmett Cunningham, Jr., MD, PhD, MPH Partner Clarus Ventures Dr. Cunningham joined Clarus Ventures with more than 20 years experience in the biomedical and biopharmaceutical sectors. Prior to Clarus, Dr. Cunningham was the Senior Vice President, Medical Strategy at Eyetech Pharmaceuticals, Inc. (NASDAQ:EYET), where he helped build and lead the team that developed and commercialized Macugen, a first-in-class product for the treatment of age-related macular degeneration. Prior to Eyetech, Dr. Cunningham was at Pfizer, Inc, where he was responsible for the clinical development of early phase central nervous system compounds and the in-licensing of early and late-stage therapeutic candidates in ophthalmology. Dr. Cunningham is an internationally recognized specialist in infectious and inflammatory eye disease with over 200 publications. He is an Adjunct Clinical Professor of Ophthalmology at Stanford University, was Clinical Professor and Director of the Uveitis service at NYU from 2002 to 2005, and was Director of both the Uveitis Service and the Kimura Ocular Immunology Laboratory at the University of California at San Francisco (UCSF) from 1995 to Dr. Cunningham received an MD and MPH in epidemiology and statistics from Johns Hopkins University, a PhD in neuroscience from the University of California at San Diego (UCSD) for work done at The Salk Institute, and completed both a residency in ophthalmology and fellowship training in Corneal Disease and Uveitis at UCSF. Dr. Cunningham is a member of the Board of Directors for SARcode Inc., a member of the Scientific Advisory Boards of ESBAtech AG and Comentis Inc., and a Board observer for Ferrokin Biosciences, Pearl Therapeutics Inc., Taligen Therapeutics Inc., and Zogenix, Inc. PricewaterhouseCoopers 5
7 Rich Ferrari Managing Director De Novo Ventures Rich has been a successful CEO of several medical technology companies, both prior to and after cofounding De Novo in Following De Novo s investment in CryoVascular Systems, Rich became CEO, growing the initial 5 person start up team to a company of 20 employees. He was instrumental in developing the clinical and product strategies and hiring the executive team. In 2002, Rich led Paracor Medical, another De Novo portfolio company. He grew the company from 4 to 22 employees, refined the product strategy, raised its Series B financing and hired his replacement CEO. Prior to co-founding De Novo Ventures, he was the co-founder and CEO of CardioThoracic Systems ( CTSI ), a company he led to an initial public offering in only 7 months in CTSI, the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery, was ultimately acquired by Guidant Corporation in November Before that, Rich was the CEO of Cardiovascular Imaging Systems ( CVIS ). As CEO, he orchestrated a successful IPO and ultimately sold the company to Boston Scientific Corporation in In addition, Rich founded Saratoga Ventures in 1996, a venture capital partnership that has provided seed financing to startup medical technology companies, including Atrionix, Oratec, Enteric Medical, Trivascular, and Endotex. At Saratoga, Rich was Chairman of Oratec, which was sold in 2001 to Smith & Nephew PLC. Mr. Ferrari also co-founded The Medical Technology Group, which spun out Integrated Vascular Systems, an early stage femoral artery closure company which was sold to Abbott and Angiosense, a needlefree, jet injection, local drug delivery company. Early in his career, Rich held the position of Executive Vice President and General Manager of ADAC Laboratories. Rich holds a BS degree from Ashland University and an MBA from the University of South Florida. Rich sits on the boards of BenVenue, CardioMind, MyoScience, Ovalis, Paracor Medical, Pulmonx, Simpirica, Spinal Kinetics and Spinal Modulation. His prior board involvement includes TriVascular. PricewaterhouseCoopers 6
8 Allan May Managing Director Emergent Medical Partners Allan has been a founder, board member and/or CEO of a number of early stage companies in medical device and biotechnology including Athenagen (an LSA company), MAST Immunosystems, Intella Interventional Systems, Quanam Medical, ImmuneTech, NuGEN Technologies, AngstroVision, IntegriGen, Imetrx, and Vascular Architects. Previously, Mr. May was Senior Vice President of Diasonics, Inc., a NYSE-listed medical imaging company manufacturing and distributing MRI, ultrasound, fluoroscopic and therapeutic devices, and President and COO of Fortune Systems Corporation, a NASDAQ-traded developer of microprocessor based file servers utilizing the Unix operating system. He also has extensive experience in negotiating and consummating mergers and acquisitions, having been involved in over 100 transactions. He co-founded Life Science Angels ( LSA ) in 2005 and currently serves as its Chairman. LSA is the largest angel organization in the United States comprised solely of life science industry veterans and investing solely in medical device and life science early stage companies. PricewaterhouseCoopers 7
9 Rich Redelfs General Partner Foundation Capital Rich joined Foundation Capital in 2004 after more than 20 years in networking and communications, amassing a combination of start-up entrepreneurial as well as large company intrapreneurial experience. Most recently, he was president and CEO of Atheros Communications, which he helped build into the leading provider of Wi-Fi wireless semiconductors; it was subsequently named "Silicon Valley's Fastest Growing Private Company" by the Silicon Valley/San Jose Business Journal and PricewaterhouseCoopers for the period. In 2003 Rich received Frost & Sullivan's prestigious "Wireless LAN CEO of the Year" award. Rich currently serves on the boards of Dust Networks, Mobius Microsystems, Prematics, ACCO Semiconductor and Ventiva, and was previously on the boards of Azimuth Systems and Atheros Communications. He has an MBA from Harvard Business School and a BSIE from Purdue. PricewaterhouseCoopers 8
10 Companies PricewaterhouseCoopers 9
11 PricewaterhouseCoopers Ten Almaden Boulevard Suite 1600 San Jose, CA Phone: PricewaterhouseCoopers (PwC) is well placed to help you meet the challenges and opportunities of the US marketplace. We offer the perspective of a global organization combined with detailed knowledge of local, state and US national issues. Formed in 1998 from a merger between Price Waterhouse and Coopers & Lybrand, PwC has a history in client services that dates back to the nineteenth century. Each accounting practice originated in London during the mid-1800s. Today, PwC serves 29 industries. Our industry-focused professionals in the fields of assurance, tax, human resources, transactions, performance improvement and crisis management help to resolve complex client and stakeholder issues worldwide. We also bring our experience and talents to help educational institutions, the federal government, non-profits, and international relief agencies address their unique business issues. PricewaterhouseCoopers 10
12 Clarus Ventures 801 Gateway Boulevard Suite 410 South San Francisco, CA Phone: (650) Clarus Ventures is a life sciences venture capital firm founded by a team of accomplished investment professionals with extensive and complementary industry backgrounds which have enabled them to establish a long history of success in creating value. Their deep relationships with world thought leaders and decision makers allow this team to identify unique investment opportunities and shepherd them to maturity. Clarus augments its core expertise of investing in biopharmaceuticals and medical technology companies with the deep and diverse expertise of the team in research and development, commercialization, business development and operations management at the global level. Clarus has $1.2 billion of assets under management across two lifesciences dedicated funds. Clarus is headquartered in Cambridge, MA, and has an office in South San Francisco, CA. PricewaterhouseCoopers 11
13 De Novo Ventures 400 Hamilton Avenue Suite 300 Palo Alto, CA Phone: (650) De Novo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would have significant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by our investment success in selected medical device and biotechnology companies. With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. We invest in all stages of enterprise development and growth from early stage to late stage. Our unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company. Eight exits have occurred in DNV I -- four IPOs: Favrille (NASDAQ: FVRL), Fox Hollow Technologies (NASDAQ: EVVV), Renovis (NASDAQ: RNVS), and SenoRx (NASDAQ: SENO) and four acquisitions: CryoVascular Systems (Boston Scientific), TriVascular (Boston Scientific), LuMend (Johnson and Johnson) and Microvention (Terumo). DNV II has had one exit to date Hansen Medical (NASDAQ: HNSN). PricewaterhouseCoopers 12
14 Emergent Medical Partners 3282 Alpine Road Portola Valley, CA Phone: (650) Emergent Medical Partners is a life sciences investment firm that focuses on medical device and healthcare companies. We have over 50 years of experience creating and investing in medical devices and healthcare companies. Our focus is on early stage companies and our expertise encompasses all areas of medicine, including cardiovascular and general surgery, orthopedic surgery, cardiology, radiology, oncology, obesity, gynecology, oncology, and sleep disorders. Often, an engineer and a physician come to us with an idea or a prototype, and we work with them to help bring about a clinical solution. We are able to find managers, engineers, and clinicians to fill any gaps in these teams. This assistance is in addition to the possible investment in the company by Emergent Medical Ventures. Most of the exits of the companies associated with our managing directors have been by acquisition. Emergent Medical Partner s network is unparalleled in Silicon Valley, as we have access to the CEO s of large and small companies throughout the United States, relationships with local hospitals to facilitate implementation of clinical trials, and relationships with the major universities in the Bay Area. Combined, these abilities help entrepreneurs while helping our investors realize superior returns. PricewaterhouseCoopers 13
15 Foundation Capital 250 Middlefield Road Menlo Park, CA Phone: (650) Foundation Capital was founded in 1995 by Bill Elmore, Kathryn Gould, and Jim Anderson with a single purpose: to build great companies. These are companies that rise upward on the strongest of all foundations the power of an idea. And as such, they are organizations that make a difference, not only in the lives of their constituents, but in the impact they have on their markets. We should know: every partner at Foundation Capital has been an entrepreneur before coming here. We have served as CEOs, as executive managers, and as technologists with a compelling idea that ultimately resulted in real-world experience directing a company to success. We continue to run Foundation Capital with this entrepreneurial spirit, because our true expertise is the understanding, the perspective, and the enthusiasm we bring to helping promising companies in their formative stages. We are, quite simply, a venture capital firm where the venture matters more than the capital. Where purpose, and hard work, count. Where people, and beliefs, matter. PricewaterhouseCoopers 14
16 Silicon Valley Bank 3005 Tasman Drive Santa Clara, CA Phone: (408) A SVB Financial Group provides diversified financial services to emerging, growth and established technology companies and the life science, venture capital and premium wine markets. Through its focus on specialized markets and extensive knowledge of the people and business issues driving them, SVB Financial Group provides a level of service and partnership that measurably impacts its clients' success. Headquartered in Santa Clara, Calif., the company offers its clients commercial, investment, merchant and private banking, as well as value-added services using its knowledge and networks. Founded in 1983, SVB Financial Group serves nearly 11,000 clients around the world through 27 domestic offices, and international subsidiaries in the U.K., Israel, India and China, and an extensive network of relationships with venture capitalists in Asia, Australia, Europe, India, and Israel. With solid understanding of the true risks and rewards faced by companies in dynamic markets, the company is widely recognized for its ability to develop innovative approaches to meet the unique financial needs of its clients. SVB Financial Group began serving the technology and life science markets at a time when they were not wellunderstood by the financial services industry and when many of the leading companies in these industries were just getting started. At that time, many of these companies had yet to show profits and were not considered creditworthy by local community or regional banks. Over the last two decades, SVB Financial Group has become one of the most respected names in the financial services industry. The company has created innovative solutions for some of the world's most successful technology and life sciences companies. These companies face unique challenges and require special services, such as finding the right venture capitalist or angel investor, securing capital to support rapid growth, or driving overseas expansion. SVB Financial Group offers products and services specifically tailored to meet our clients' needs at every stage of corporate growth. PricewaterhouseCoopers 15
17 Presentation PricewaterhouseCoopers 16
18 Q2 Update: September 2009 Shaking the MoneyTree Steve Bengston PricewaterhouseCoopers/ National Venture Capital Association MoneyTree Report
19 About The Report PricewaterhouseCoopers and the National Venture Capital Association produce the MoneyTree Report Core measure of equity investments in venture-backed companies in the United States Companies have received at least one round of financing involving a professional VC firm or equivalent Captures: tranches, note term sheets, foreign VCs, qualified private placement Excludes: debt, bridge loans, recaps, roll-ups, IPOs, PIPEs, leasing, etc. MoneyTree Report in its 14th year Results online at Slide 2
20 MoneyTree Total Investments: Q ($ in billions) $14.0 $12.0 $12.5 $10.0 $10.9 Q1 $8.0 $6.0 $4.0 $2.0 $8.1 $7.8 $6.6 $5.9 $4.4 $4.4 $4.2 $4.8 $4.7 $5.5 $5.2 $6.1 $4.9 $5.8 $5.0 $6.3 $5.8 $5.8 $6.3 $7.1 $6.6 $6.3 $7.4 $7.4 $7.8 $8.0 $7.7 $7.6 $7.2 $5.7 $3.2 $3.7 Q2 Q3 Q4 $ # of Deals Q1 Q2 Q Q4 982 Q1 841 Q2 850 Q3 692 Q4 722 Q1 704 Q2 742 Q3 719 Q4 787 Q1 716 Q2 852 Q3 694 Q4 842 Q1 732 Q2 829 Q3 791 Q4 815 Q1 880 Q2 962 Q3 911 Q4 952 Q1 867 Q2 Q3 Q4 Q1 Q Q3 980 Q4 884 Q1 603 Q2 612 Q3 Q4 Slide 3
21 MoneyTree Total Investments: 1980 YTD 2009 ($ in billions) Annual Venture Capital Investments 1980 to YTD 2009 $120 $0.5 $1.1 $1.5 $2.8 $2.9 $2.7 $2.9 $3.2 $3.2 $3.2 $2.6 $2.1 $3.4 $3.5 $4.0 $7.6 $10.8 $14.4 $20.2 $52.0 $39.3 $21.3 $19.3 $22.1 $22.9 $26.3 $30.6 $28.1 $6.9 $101.8 $100 $80 $60 $40 $20 $ Slide 4
22 NIIHA U KA U AI O AHU MOLOKAI LANAI KAHOOLA WE MA UI HA W AII Investments by Region: Sacramento/N. CA $7.3 M 4 Deals 0% of US total Silicon Valley $1,176.7 M 174 Deals 32% of US total LA/Orange County $159.0 M 30 Deals 4% of US total San Diego $172.2 M 22 Deals 5% of US total AK/HI/PR $0 M 0 Deals 0% of US total Northwest $126.7 M 35 Deals 3% of US total Colorado $211.1 M 16 Deals 6% of US total Southwest $157.9 M 18 Deals 4% of US total North Central $100.7 M 15 Deals 3% of US total Texas $74.1 M 23 Deals 2% of US total South Central $5.8 M 7 Deals 0% of US total Midwest $201.2 M 52 Deals 5% of US total Southeast $282.3 M 34 Deals 8% of US total Upstate NY $2.6 M 2 Deals 0% of US total DC/Metroplex $89.8 M 26 Deals 2% of US total New England $466.9 M 76 Deals 13% of US total NY Metro $276.2 M 54 Deals 8% of US total Philadelphia Metro $161.9 M 22 Deals 4% of US total Unknown region totals are not included in the map Total Investments - $3,674.4 million in 612 deals Slide 5
23 Investments by Region: ($ in millions) Silicon Valley $1,176.7 New England Southeast $282.3 $466.9 Region # of Deals % Change $ from Q1 09 NY Metro $276.2 Silicon Valley 174-8% Colorado $211.1 New England 76 15% Midwest San Diego Philadelphia Metro $201.2 $172.2 $161.9 Southeast NY Metro Colorado Midwest % -18% 158% 53% LA/Orange County SouthWest Northwest $159.0 $157.9 $126.7 San Diego Philadelphia Metro LA/Orange County SouthWest % 418% -24% 280% North Central DC/Metroplex Texas Sacramento/N.Cal South Central $7.3 $5.8 $100.7 $89.8 $74.1 Northwest North Central DC/Metroplex Texas Sacramento/N.Cal South Central Upstate NY % 66% 13% -58% 4% -44% 57% Upstate NY AK/HI/PR $2.6 AK/HI/PR Total % 15% $0 $100 $200 $300 $400 $500 $600 $700 $800 $900 $1,000 $1,100 $1,200 Total: $3,674.4 million in 612 deals Unknown region totals are not included in the chart Slide 6
24 Investments by Region Quarterly Percent of Total U.S. Investments (% of Total Dollars) Top U.S. Regions Q2 08 Q % 40% 40.34% 38.74% 35.93% 39.98% 32.03% 30% 20% 10% 10.93% 11.92% 13.58% 12.70% 12.71% 4.30% 3.44% 4.86% 3.56% 7.68% 5.30% 7.36% 6.92% 10.54% 7.52% 2.47% 2.91% 2.87% 2.56% 5.75% 0% Silicon Valley New England Southeast NY Metro Colorado Q2 '08 Q3 '08 Q4 '08 Q1 '09 Q2 '09 Slide 7
25 Silicon Valley Market Share of US VC $: '95 '97 '99 '01 '03 '05 '07 Q1'09 SV % Slide 8
26 All Deals ($M): Silicon Valley Slide 9 Q1 '95 Q3 '95 Q1 '96 Q3 '96 Q1 '97 Q3 '97 Q1 '98 Q3 '98 Q1 '99 Q3 '99 Q1 '00 Q3 '00 Q1 '01 Q3 '01 Q1 '02 Q3 '02 Q1 '03 Q3 '03 Q1 '04 Q3 '04 Q1 '05 Q3 '05 Q1 '06 Q3 '06 Q1'07 Q3'07 Q1'08 Q3'08 Q1'09 $M Deals
27 All Deals (#): Silicon Valley Slide 10 Q1 '95 Q3 '95 Q1 '96 Q3 '96 Q1 '97 Q3 '97 Q1 '98 Q3 '98 Q1 '99 Q3 '99 Q1 '00 Q3 '00 Q1 '01 Q3 '01 Q1 '02 Q3 '02 Q1 '03 Q3 '03 Q1 '04 Q3 '04 Q1 '05 Q3 '05 Q1 '06 Q3 '06 Q1'07 Q3'07 Q1'08 Q3'08 Q1'09 # Deals
28 Series A Deals ($M): Silicon Valley Slide 11 Q1 '95 Q3 '95 Q1 '96 Q3 '96 Q1 '97 Q3 '97 Q1 '98 Q3 '98 Q1 '99 Q3 '99 Q1 '00 Q3 '00 Q1 '01 Q3 '01 Q1 '02 Q3 '02 Q1 '03 Q3 '03 Q1 '04 Q3 '04 Q1 '05 Q3 '05 Q1 '06 Q3 '06 Q1'07 Q3'07 Q1'08 Q3'08 Q1'09 $M Deals
29 Series A Deals (#): Silicon Valley Slide 12 Q1 '95 Q3 '95 Q1 '96 Q3 '96 Q1 '97 Q3 '97 Q1 '98 Q3 '98 Q1 '99 Q3 '99 Q1 '00 Q3 '00 Q1 '01 Q3 '01 Q1 '02 Q3 '02 Q1 '03 Q3 '03 Q1 '04 Q3 '04 Q1 '05 Q3 '05 Q1 '06 Q3 '06 Q1'07 Q3'07 Q1'08 Q3'08 Q1'09 # Deals
30 Silicon Valley Inv. By Round: Q $ M 50 0 A B C D E F G H I J K L M N O P Slide 13
31 Silicon Valley Inv. By Round: $ M 50 0 A B C D E F G H I J K L M N O Slide 14
32 Investments by Industry: ($ in millions) Biotechnology $888.1 Software $644.1 Medical Devices and Equipment $628.4 IT Services Industrial/Energy Networking and Equipment Semiconductors Computers and Peripherals Media and Entertainment Telecommunications Electronics/Instrumentation Business Products and Services Consumer Products and Services $180.3 $170.2 $131.5 $115.8 $94.9 $84.6 $49.5 $43.5 $295.1 $286.5 Industry Biotechnology Software Medical Devices and Equipment IT Services Industrial/Energy Networking and Equipment Semiconductors Computers and Peripherals Media and Entertainment Telecommunications Electronics/Instrumentation Business Products and Services Consumer Products and Services # of Deals % Change $ from Q % 0.98% 38.80% 28.22% % % -5.15% % % % % % % Healthcare Services Retailing/Distribution $22.8 $17.7 Healthcare Services Retailing/Distribution Financial Services % % % Financial Services Other $15.7 $5.7 Other TOTAL % 15.14% $0 $100 $200 $300 $400 $500 $600 $700 $800 $900 $1,000 Total: $3,674.4 million in 612 deals Visit for Industry definitions Slide 15
33 Investments by Industry Quarterly Percent of Total U.S. Investments (% of Total Dollars) 30% Top 5 Industries Q2 08 to Q % 24.17% 20% 15% 10% 5% 14.05% 17.21% 18.44% 18.07% 16.29% 18.82% 18.75% 19.99% 17.53% 12.11% 12.89% 10.34% 14.19% 17.10% 7.89% 6.00% 4.71% 7.21% 8.03% 15.51% 17.65% 16.49% 10.03% 7.80% 0% Biotechnology Software Medical Devices and Equipment IT Services Industrial/Energy Q2 '08 Q3 '08 Q4 '08 Q1 '09 Q2 '09 Slide 16
34 Life Science Investments Percent of Total U.S. Investments Life Science Sectors Q2 08 to Q2 09 (% of Total Dollars) 45% 40% 35% 30% 25% 20% 15% 10% 14.05% 17.20% 18.44% 18.07% 24.17% 12.11% 12.89% 10.34% 14.19% 17.10% 26.17% 30.10% 28.79% 32.26% 41.27% 5% 0% Biotechnology Medical Devices and Equipment Life Sciences Q2 '08 Q3 '08 Q4 '08 Q1 '09 Q2 '09 Slide 17
35 Life Science $ Invested as % Total: YTD '01 '03 '05 '07 '09 YTD LS % Tot Slide 18
36 MoneyTree Cleantech Investments: Q ($ in millions) $1,200 $1,000 $800 $600 $400 $200 $41.9 $136.5 $75.7 $186.3 $157.9 $128.0 $116.4 $120.6 $287.7 $402.3 $522.9 $245.5 $460.4 $586.5 $892.5 $716.6 $1,089.8 $910.8 $1,045.4 $977.3 $238.3 $274.4 Q1 Q2 Q3 Q4 $ # of Deals Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q Slide 19
37 Cleantech Investments by Sub-sector Top cleantech sub-sectors Q ($ in millions) $500 $400 $430.0 $420.1 $446.9 $460.0 $300 $271.2 $200 $100 $0 $81.1 Solar Energy 50.6 $162.3 $129.9 $87.8 $ Alternative Fuels (includes biofuels) $39.0 $26.4 $43.7 $96.8 $ Energy Storage (includes vehicular battery technology) $43.8 $10.7 $71.5 $15.6 $ Transportation (includes electric vehicles) $95.1 $141.8 $125.6 $43.9 $ Pollution and Recycling (includes water technology) $26.1 $13.2 $69.3 $7.0 $ Wind and Geothermal Energy Q Q Q Q Q Slide 20
38 Investments by Cleantech Sub-Sector Percent of Total Cleantech Investments (% of Total Cleantech Dollars) Top cleantech sub-sectors Q % 40% 39% 46% 43% 47% 34% 30% 25% 20% 10% 0% Solar Energy 18% 18% 12% 9% 14% 18% Alternative Fuels (includes biofuels) 4% 3% 4% 10% 6% 11% Energy Storage (includes vehicular battery technology) 4% 1% 7% 2% 8% 1% Transportation (includes electric vehicles) 9% 16% 12% 4% 13% 0% Pollution and Recycling (includes water technology) 2% 1% 7% 1% 2% 0% Wind and Geothermal Energy Q Q Q Q Q Slide 21
39 Cleantech investments by Region: Second Quarter 2009 ($ in millions) Silicon Valley $112.1 LA/Orange County $30.0 Northwest $28.6 Colorado Southeast NY Metro $20.7 $20.1 $26.6 Region Silicon Valley LA/Orange County Northwest # of Deals % Change $ from Q % 8% 64% North Central DC/Metroplex $13.9 $10.1 Colorado Southeast NY Metro % NA 3674% New England Philadelphia Metro South Central Sacramento/N.Cal Midwest $6.5 $4.0 $1.4 $0.2 $0.2 North Central DC/Metroplex New England Philadelphia Metro South Central Sacramento/N.Cal Midwest SouthWest Total % 13791% -79% 433% NA NA -98% -99% 15% SouthWest $0.1 $0 $15 $30 $45 $60 $75 $90 $105 Visit for Region definitions Total: $274.4 million in 42 deals Slide 22
40 Cleantech investments by Region: 1H 2008 vs 1H 2009 (% of total Cleantech investment) Silicon Valley LA/Orange County Northwest Colorado New England Southeast NY Metro North Central San Diego Midwest Texas SouthWest DC/Metroplex Philadelphia Metro 4% 4% 4% 4% 0% 3% 3% 3% 3% 2% 2% 2% 1% 2% 2% 1% 3% 8% 9% 6% 9% 7% 8% 7% 11% 12% 39% 41% 1H H % 10% 20% 30% 40% 50% Visit for Region definitions Slide 23
41 Investments by Stage of Development: ($ in millions) Later Stage $1,155.2 Expansion $1,028.8 Early Stage $1,015.9 Stage of Development # of Deals % Change in $ Amount from Q Later Stage % Expansion Stage % Early Stage % Startup/Seed $474.6 Startup/Seed Total % 15.14% $0 $500 $1,000 $1,500 $2,000 Total: $ million in 612 deals Slide 24
42 Investments by Sequence of Financing: ($ in millions) 5th and Beyond $1,149.8 Second $750.6 First $678.2 Financing # of Deals % Change in $ Amount from Q th and Beyond % Second % Third $553.5 First % Third % Fourth $542.2 Fourth Total % 15.14% $0 $500 $1,000 $1,500 Total: $3,674.4 million in 612 deals Slide 25
43 First Sequence Financing Number of Deals 500 First Sequence Deals Q1 Q2 Q3 Q4 Slide 26
44 First Sequence Financing Investment Amount $4 ($ in billions) First Sequence Investments $2.0 $1.3 $1.2 $1.3 $1.2 $1.0 $0.8 $0.8 $1.0 $1.1 $1.1 $1.0 $1.3 $1.2 $1.3 $1.4 $1.5 $1.4 $1.4 $1.4 $1.7 $1.6 $1.4 $1.6 $1.8 $2.0 $2.1 $1.7 $1.7 $1.6 $1.2 $0.6 $0.7 $2.8 $3 $2 $1 $ Q1 Q2 Q3 Q4 Slide 27
45 First Sequence Financing Percent of Total U.S. Investments 60% 55% 50% 45% 40% 35% 30% 25% 20% 15% 34.9% 34.9% 34.6% 32.1% 32.6% 33.8% 32.7% 32.0% 31.3% 29.5% 30.4% 31.0% 31.4% 30.4% 30.3% 27.9% 28.7% 26.5% 25.9% 25.1% 25.6% 27.7%27.2% 29.2% 34.4% 32.8% 24.9% 23.8% 24.7% 22.0% 22.1% 22.4% 23.0% 26.9% 21.6% 28.4% 25.3% 26.1% 25.1% 24.3%24.4% 23.9% 23.8% 22.4% 22.9% 21.6% 22.3% 19.5% 20.5% 22.1% 23.9% 20.2% 20.5% 20.3%20.0%20.9% 19.5%18.5% 18.2%18.0% 10% 5% 0% Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q % of Total Dollars % of Total Deals Slide 28
46 Stage of Development Quarterly Percent of Total First Sequence Dollars (% of first sequence dollars) 60% Stage Development Q to 50% 40% 30% 20% 17.62% 18.42% 19.59% 20.16% 42.90% 40.02% 35.94% 42.09% 38.37% 30.22% 27.85% 26.42% 21.90% 23.39% 22.36% 14.52% 19.22% 16.42% 18.09% 10% 4.52% 0% Startup/Seed Early Stage Expansion Later Stage Q2 '08 Q3 '08 Q4 '08 Q1 '09 Q2 '09 Slide 29
47 Stage of Development Quarterly Percent of Total First Sequence Deals (% of first sequence deals) 60% Stage Development Q to 50% 40% 30% 20% 10% 26.43% 31.47% 26.38% 25.50% 22.70% 45.95% 41.26% 44.49% 43.62% 48.94% 17.12% 14.69% 17.32% 16.11% 20.57% 10.51% 12.59% 11.81% 14.77% 7.80% 0% Startup/Seed Early Stage Expansion Later Stage Q2 '08 Q3 '08 Q4 '08 Q1 '09 Q2 '09 Slide 30
48 First Sequence Deals in Startup & Early Stage Companies 90% % 63.6% 63.3% 66.9% 72.4% 74.2% 2, % 71.6% 76.7% 74.9% 70.4% 71.0% 72.2% 70.8% 70.3% 80% 70% 60% % 40% ,765 30% % 10% 0 0% Seq 1 Deals in Startup/Early Stage % of Total Seq 1 Deals YTD Slide 31
49 Median Deal Size vs. Mean Deal Size Quarterly Total U.S. Investments $10 $8.6 $8 $6 $6.0 $6.5 $6.6 $7.0 $7.3 $7.2 $7.1 $6.9 $6.9 $7.6 $7.4 $7.4 $7.1 $7.2 $7.2 $6.7 $7.0 $7.8 $7.5 $7.6 $7.1 $7.3 $6.4 $5.3 $6.0 $4 $3.4 $3.8 $3.6 $4.0 $4.5 $4.2 $4.5 $4.5 $4.2 $4.3 $3.9 $4.5 $4.2 $4.0 $4.0 $3.5 $4.1 $4.2 $3.8 $4.0 $4.0 $3.5 $3.5 $2.5 $3.0 $2.2 $2 $0 Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Median Deal Size Mean Deal Size Slide 32
50 Top 10 Deals : Q ($ Millions) Solyndra Silicon Valley Cleantech $219 Pocket Communications San Antonio Telco 100 Silver Spring Networks Silicon Valley Cleantech 75 Biolex Therapeutics North Carolina Biotech 60 i/o Data Centers Phoenix IT Services 56 Boston Power Boston Cleantech 55 Pacira Pharma New Jersey Biotech 55 Bayhill Therapeutics Silicon Valley Biotech 54 Kosmos Energy Dallas Cleantech 54 Calisolar Silicon Valley Cleantech 52 Slide 33
51 Top 10 Deals : Q ($ Millions) Anacor Pharmaceuticals Silicon Valley Biotech $ 50 Ardian Silicon Valley Med Device 47 SFJ Pharma Silicon Valley Biotech 45 Pathway Medical Seattle Med Device 40 BioVex Boston Biotech 40 Green Bullions Miami Industrial/Energy 40 Kosmos Energy Dallas Cleantech 39 Obopay Silicon Valley Financial Services 35 Twitter Silicon Valley Software 35 Quadriserv NY Software 34 Slide 34
52 Top 10 Deals : ($ Millions) Clovis Oncology Boulder Biotech $146 Workday Silicon Valley Software 75 ExactTarget Indianapolis IT Services 70 Hyperion Therapeutics Silicon Valley Biotech 60 PhotoThera Carlsbad Med Device 50 Phoenix Services Unionville, PA Cleantech 50 Fusion-io Salt Lake City Comp & Peripherals 48 Cempra Pharma Chapel Hill, NC Biotech 46 Revolution Money Saint Petersburg Software 42 LifeLock Tempe IT Services 40 Slide 35
53 Most Active Venture Investors Venture Capital Firm Canaan Partners Innovation Works, Inc. Kleiner Perkins Caufield & Byers New Enterprise Associates Polaris Venture Partners Duff Ackerman & Goodrich LLC First Round Capital U.S. Venture Partners Draper Fisher Jurvetson Alta Partners ARCH Venture Partners Highland Capital Partners LLC Novak Biddle Venture Partners, L.P. Venrock Associates OVP Venture Partners Redpoint Ventures Location Westport, Connecticut Pittsburgh, Pennslyvania Menlo Park, California Baltimore, Maryland Waltham, Massachusetts San Fransisco, California West Conshokocken, Pennslyvania Menlo Park, California Menlo Park, California San Fransisco, California Chicago, Illinois Lexington, Massachusetts Bethesda, Maryland Palo Alto, California Kirkland, Washington Menlo Park, California Total Deals Slide 36
54 Q Venture Capital Performance US Venture Capital Index Returns for the Periods ending 3/31/2009, 12/21/2008 and 3/31/2008 For the period ending 1 st Qtr. 1 Year 3 Years 5 Years 10 Years 15 Years 20 Years March 31, December 31, March 31, Other indices at March 31, 2009 DIJA SDAQ Composite S&P Source: Cambridge Associates LLC Note: Because the US Venture Capital index is cap weighted, the largest vintage years mainly drive the index s performance. Slide 37
55 Analysis of Venture-Backed IPO and M&A Activity Date Number of IPOs* Total Venture- Backed Offering Size ($M) Average Venture- Backed Offering Size ($M) Number of Venture-backed M&A deals Average M&A deal size** , , , , Q Q Q Q Q Q Source: Thomson Reuters and National Venture Capital Association * Includes all companies with at least one U.S. VC investor that trade on U.S. exchanges, regardless of domicile **Only accounts for deals with disclosed values Slide 38
56 Venture Backed Exits: #M&A vs #IPO M&A IPO '02 '04 '06 '08 Slide 39
57 Venture Capital Fundraising Year Quarter Q2 07 Q3 07 Q4 07 Q1 08 Q2 08 Q3 08 Q4 08 Q1 09 Q2 09 First Time Funds Source: Thomson Reuters & National Venture Capital Association 3 8 Follow-On Funds Total Number of Funds VC Raised ($M) 19, , , , , , , , , , , , , ,701.9 Data current as of July 13, 2009 Slide 40
58 Summary: Good News Full Year 2008 $28 B, 5 th biggest ever Worldwide Cleantech Investments (Innovas Solutions) - US 21%, China 14%, Japan & India 6%, Advertising $ to Internet/Mobile just begun (7%) - Worldwide Ad Spending $600B - 21% media time Internet/Mobile Big Trends still exist -Cleantech -Cloud Computing -Virtualization -Demographic/Geographic shifts -Analytics: Extracting signal from noise -Advertising to Internet/Mobile Cisco acquiring again Actona Airespace Arroyo Video Solutions Dynamicsoft FineGround Networks IronPort Systems Linksys Meetinghouse Navini Networks NetSolve Orative P-Cube Perfigo Post path Pure Digital Pure Networks Protego Networks Reactivity Scientific Atlanta Securent Sheer Networks SignalWorks Tidal Software Topspin $ 82m 450m 92M 55m 70m 830m 500m 44m 330m 128m 31m 200m 74m 215m 590M 120m 65m 135m 6900m 100m 97M 14m 105m 250M Slide 41
59 Summary: Not So Good News IPO mkt weak - 6 vc backed IPO s in US in 08, lowest since 1977, raised $0.5B vs $10.3B in 07-5 vc backed IPO s 1st half : 1776 IPO s, 56% all exits : 392 IPO s, 13% all exits $3.0B invested in Q1 09 lowest since Q1 97, 62% drop vs Q1 08, 44% drop vs Q4 08 M&A weak - Q1 09: 56 deals, down 47% vs Q1 08, lowest # in decade - Q2 09: 67 deals for $2.8 B, down 60% vs Q2 08, 80% vs Q Median M&A about $22M in Q1 09 & Q2 09, $16M in ave. Q2 deal - $4 Trillion mkt cap lost on US exchanges in last 12 months, e.g. - Citigroup: $130B gone, AIG: $150B, Fannie Mae/Freddie Mac: $105B ($1B left) US Homeowners lost $6 Trillion equity last 3 years - 12 Million homes worth less than mortgage Employment down 2 million jobs in 08, US unemployment at 26 year high - Silicon Valley unemployment 11.8% June 09 vs. 6% June 08 US household net worth shrank to $50 trillion in 09 vs $62 trillion in 07 US government recently borrowed 10% of budget, 45% of budget in 09 Slide 42
60 Summary/Predictions VC Market: Men Behaving Badly VC s stop funding many portfolio companies, major triage More layoffs/cost cutting, unemployment up New Deals must be perfect All Deals Series A, lots of down rounds Fewer Deals per fund, higher reserves VC syndicate quality more important, lots inside rounds (57% Q1) VC s fear capital calls produce LP defaults VC Fundraising problematic: $6.3B in 1 st half 09, 62% drop vs 08 More Government regulation Slide 43
61 Globalization Marches On China VC$ : 4.2B 08, 2.5B 07, 1.3B 04 China VC$ raised $7.3B 08 India VC$: $3.0B 08, 0.6B 04 Japan VC$: $1.9B 08, 1.5B 04 Israel VC$: $1.4B 08, $1.2B in 07 & 06 % Int l: 70% PC, 86% Internet, 92% Mobile China surpass US for most Internet users in 08, 67% under 29 Asia 43% of Internet users by 2013 China as new IMF for US - Balanced budget, devalued currency, higher interest rates, relaxed - Regulation, tax cuts Australian commentator: Need Communists to save Capitalism China 2 nd largest economy by 2025 India population surpass China by 2020 Slide 44
62 Steve Bengston PricewaterhouseCoopers LLP. All rights reserved. "PricewaterhouseCoopers" refers to PricewaterhouseCoopers LLP (a Delaware limited liability partnership) or, as the context requires, other member firms of PricewaterhouseCoopers International Ltd., each of which is a separate and independent legal entity. *connectedthinking is a trademark of PricewaterhouseCoopers LLP. SJ_07_0080
Steve Bengston
VC Outlook 2009: Looking Down the Money Trail Steve Bengston steve.bengston@us.pwc.com 650 281 9843 PricewaterhouseCoopers/ National Venture Capital Association MoneyTree Report MoneyTree Total Investments:
More informationShaking the MoneyTree TM Q Update
www.pwc.com Shaking the MoneyTree TM Update PricewaterhouseCoopers/National Venture Capital Association MoneyTree TM Report based on data from Thomson Reuters HJ Paik Director, Emerging Company Services
More informationShaking the MoneyTree TM Q Update
www.pwc.com Shaking the MoneyTree TM Q1 2015 Update PricewaterhouseCoopers/National Venture Capital Association MoneyTree TM Report based on data from Thomson Reuters HJ Paik Director, Emerging Company
More informationMoneyTree Report Q PricewaterhouseCoopers National Venture Capital Association. Data provide by Thomson Reuters.
www.pwcmoneytree.com PricewaterhouseCoopers National Venture Capital Association TM MoneyTree Report Data provide by Thomson Reuters The MoneyTree results are in! This special report provides summary results
More informationPricewaterhouseCoopers National Venture Capital Association. Report. Data provided by Thomson Reuters
PricewaterhouseCoopers National Venture Capital Association Data provided by Thomson Reuters Report Q1 2010 US results The Q1 2010 MoneyTree results are in! This special report provides summary results
More informationMoving Ahead. Third-quarter Technology venture capital investment increased 33 percent yearover-year. percent quarter-over-quarter.
Moving Ahead Third-quarter Technology venture capital investment increased 33 percent yearover-year but decreased 6 percent quarter-over-quarter October 2 PwC US venture capital funding for the Technology
More informationThe MoneyTree Report. Overview of Venture Capital Investments Second Quarter 2008
The MoneyTree Report Overview of Venture Capital Investments Second Quarter 2008 PricewaterhouseCoopers/National Venture Capital Association MoneyTree Report based on data from Thomson Reuters 1 Host of
More informationPwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease
More informationMedtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year
www.pwc.com Medtech Slowdown Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year February 2014 2 PwC US venture capital funding for
More informationVENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT
Contacts: Clare Chachere, PwC US, 512-867-8737, clare.chachere@us.pwc.com Jeffrey Davidson, Brainerd Communicators for PwC, 212-739-6733, davidson@braincomm.com Ben Veghte, NVCA, 703-778-9292, bveghte@nvca.org
More informationVenture Capital Research Report Q4 2017
Venture Capital Research Report Q4 2017 As of February 9, 2018 Executive Summary VC market in the US Regional share of investment VC market in the SF Bay Area Annual VC investment in the SF Bay Area VC
More informationECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT
A Summary of the San Diego Regional Economy UNEMPLOYMENT San Diego Regional EDC analyzes key economic metrics that are important to understanding the regional economy and San Diego's standing relative
More informationVenture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010
CONTACTS Channa Brooks Tenor Communications for NVCA 1.302.368.2345 channa@tenorcom.com Daniel Billings Thomson Reuters 1.646 223 5985 daniel.billings@thomsonreuters.com Exit Activity Shows Improved Signs
More information1- History of Silicon Valley Cluster Formation. Core Universit 1891 Stanford University founded. University-originated VB Activity
1- History of Silicon Valley Cluster Formation 1890 1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 (Since 1890)10 20 30 40 50 60 70 80 90 100 110 Core Universit 1891 Stanford University founded
More information2011 Angel Group Year in Review
2011 Angel Group Year in Review What is the Halo Report? Angel Group Investment Trends: The Angel Resource Institute, Silicon Valley Bank and CB Insights set out to raise awareness of early stage investment
More informationVENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000
CONTACTS Laura Cruz Tenor Communications for NVCA 1.917.406.7517 laura@tenorcom.com Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN
More informationAverage M&A Deal Size at Highest Level Since 2004
CONTACTS Ben Veghte NVCA 1.703.778.9292 bveghte@nvca.org Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY MAINTAINS MOMENTUM WITH BEST QUARTER
More informationOverview of Venture Equity
Overview of Venture Equity SVB Analytics Report 2017 Written by SVB Analytics: Steve Liu Managing Director sliu@svb.com Sean Lawson Senior Manager slawson2@svb.com Steven Pipp Senior Associate spipp@svb.com
More informationThe MoneyTree Report. Overview of Venture Capital Investments Third Quarter 2009
The MoneyTree Report Overview of Venture Capital Investments Third Quarter 2009 PricewaterhouseCoopers/National Venture Capital Association MoneyTree Report based on data from Thomson Reuters 1 Host of
More informationVentureSource U.S. -- 4Q 2013
U.S. -- 4Q 2013 The following report presents DJX VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive
More informationFINC915 Venture Lab Participating Firms: FALL 2009
FINC915 Venture Lab Participating Firms: FALL 2009 and allowing the fund members to capitalize on high-growth opportunities. LOCAL FIRMS: MK Capital Task description: various Location: Northbrook, IL Fund
More informationECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT
A Summary of the San Diego Regional Economy Brought to you by analyzes key economic metrics that are important to understanding the regional economy and San Diego s standing relative to other major metropolitan
More informationSilicon Valley Venture Capital Survey Second Quarter 2018
fenwick & west Silicon Valley Venture Capital Survey Second Quarter 2018 Full Analysis Silicon Valley Venture Capital Survey Second Quarter 2018 fenwick & west Full Analysis Cynthia Clarfield Hess, Mark
More informationIVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.
IVC-MEITAR HIGH-TECH EXITS H1/ 215 REPORT IVC-Meitar 214 Exits Report Prepared by IVC Research Center Ltd. Israeli High-Tech Exit Highlights Exit proceeds in H1/215 reached ¾ of total exits for 214 Average
More informationAngel Group Update: Q2 2013
Angel Group Update: Q2 2013 Table of Contents Q2 2013 Highlights p. 4 National Trends p. 6 Most Active Angels p.13 Regional Trends p. 16 Sector Trends p. 21 About the Halo Report p. 24 2 Q2 2013 Highlights
More information2013 venture capital trends summary
213 venture capital trends summary Prepared by: Hitesh Kothari, Director, McGladrey LLP hitesh.kothari@mcgladrey.com August 213 Fundraising by venture capital funds In the first half of 213, 88 venture
More informationClick to edit Master title style The State of the Venture Capital Industry Click to edit Master text styles
The State of the Venture Capital Industry Bobby Franklin President Third & level CEO of NVCA Southeast Venture Conference March 16 Overview Click Venture to edit capital Master stats text at-a-glance styles
More informationTrends in Healthcare Investments and Exits 2018
Trends in Healthcare Investments and Exits 208 208 Massachusetts Life Science Innovation Day Clark Hayes Managing Director Life Science/Healthcare Northeast Head of Business Development SVB Corporate Overview
More informationPwC / CB Insights Healthcare MoneyTree Report
PwC / CB Insights Healthcare MoneyTree Report Q4 2017 01 US Healthcare Trends 02 US Healthcare Industries 03 US Healthcare Places 04 US Healthcare Movers and Shakers 05 Global Healthcare Trends 1 2 3 With
More informationECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT
A Summary of the San Diego Regional Economy Brought to you by San Diego Regional EDC analyzes key economic metrics that are important to understanding the regional economy and San Diego s standing relative
More informationFall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE
Fall 2015 State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Industry Overview The expansion of Florida s biotech industry remains resilient with an overall growth rate of 92% in the number
More informationVENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE
CONTACTS Laura Cruz Tenor Communications for NVCA 1.917.406.7517 laura@tenorcom.com Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY KEEPS
More informationSVB FINANCIAL GROUP FORM 8-K. (Current report filing) Filed 07/25/00 for the Period Ending 07/25/00
SVB FINANCIAL GROUP FORM 8-K (Current report filing) Filed 07/25/00 for the Period Ending 07/25/00 Address 3003 TASMAN DR SANTA CLARA, CA 95054 Telephone 4086547400 CIK 0000719739 Symbol SIVB SIC Code
More informationJim Labe. The Global Leader in Venture Finance
Jim Labe CHIEF EXECUTIVE OFFICER & CO-FOUNDER Jim Labe is the Chief Executive Officer and co-founder of TriplePoint Capital. Mr. Labe is widely recognized as the pioneer of the venture leasing and lending
More informationIsrael Venture Capital Investments Report Q3 2017
Israel Venture Capital Investments Report Q3 2017 NOVEMBER 2017 Summary of Israeli Venture Capital Raising Q3/2017 +14% from Q2/2017 Israeli high-tech capital raising summed up to $1.44B @ ALL RIGHTS RESERVED.
More informationThelander 2016 PRIVATE COMPANY YEAR END MERIT INCREASE PITCHBOOK REPORT. J. Thelander Consulting
Thelander 2016 PRIVATE COMPANY YEAR END MERIT INCREASE PITCHBOOK REPORT J. Thelander Consulting 165 Marlin Mill Valley, CA 94941 jt@jthelander.com jthelander.com +1 415.383.7006 Legal Notice: The Thelander
More informationCo C m o pa p n a y n Pr P o r f o il i e l Nove v mb m e b r r
Company Profile November 2011 Migdal Underwriting & Business initiatives Ltd. Company Profile Migdal Underwriting & Business initiatives Ltd., is the investment banking arm of the Migdal Group, one of
More informationECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT
A Summary of the San Diego Regional Economy Brought to you by San Diego Regional EDC analyzes key economic metrics that are important to understanding the regional economy and San Diego s standing relative
More informationIntentionality: Competing in the 21 st Century
Intentionality: Competing in the 21 st Century America s First Road Trip Horatio Nelson Jackson, Sewall K. Crocker & Bud 1-2 December 2009 Source: www.pbs.org Six Converging Forces Globalization Environmental
More informationJim Labe. The Global Leader in Venture Finance
Jim Labe CHIEF EXECUTIVE OFFICER & CO-FOUNDER Jim Labe is the Chief Executive Officer and co-founder of TriplePoint Capital. Mr. Labe is widely recognized as the pioneer of the venture leasing and lending
More informationTrends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010)
Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010) Background We analyzed the terms of venture financings for 126 companies headquartered in Silicon Valley that reported raising
More informationSilicon Valley Venture Capital Survey Third Quarter 2017
fenwick & west Silicon Valley Venture Capital Survey Third Quarter 2017 Full Analysis Silicon Valley Venture Capital Survey Third Quarter 2017 fenwick & west Full Analysis Cynthia Clarfield Hess, Mark
More informationFrançois G. Laugier's Representative Experience
François G. Laugier's Representative Experience Practice Area: International, Mergers & Acquisitions Key Issues: Acquisitions (For Buyer) Client Type: Foreign Publicly-Traded Naval Technology Company Description:
More informationNEW GENERATION OF VCs LEADS STARTUP CEOs BACK TO THE FOLD
April 2012 THE PENDULUM SWINGS IN FUNDING: NEW GENERATION OF VCs LEADS STARTUP CEOs BACK TO THE FOLD 2 Survey Overview The Palo Alto office of Dorsey & Whitney embarked on their second market survey of
More informationThe percentage of Series A rounds declined significantly, to 12% of all deals.
Silicon Valley Venture Capital Survey Fourth Quarter 2012 Barry Kramer and Michael Patrick Fenwick fenwick & west llp Background We analyzed the terms of venture financings for 116 companies headquartered
More informationBuilding on Innovation
Building on Innovation America s First Road Trip Horatio Nelson Jackson, Sewall K. Crocker & Bud 1-2 December 2009 Source: www.pbs.org Sweeping Away the Old Rules Globalization Technology Demographics
More informationECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT
A Summary of the San Diego Regional Economy Brought to you by San Diego Regional EDC analyzes key economic metrics that are important to understanding the regional economy and San Diego s standing relative
More informationRaymond A. Snead, Jr., D. Sc., FHFMA, FACHE
Doctor of Healthcare Administration and currently practicing CFO whose thirty-five-year career includes serving as the President, Executive Vice President and Chief Financial Officer of for profit and
More informationWOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview
Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context
More informationTECH START-UP CONNECTING ACROSS GEOGRAPHIES
#ML15MayRathon TECH START-UP CONNECTING ACROSS GEOGRAPHIES Andrew Ray, Partner, Washington DC William Perkins, Partner, Boston James Chapman, Partner, Silicon Valley Joseph Statter, Managing Director,
More informationOmeros Raises More Than $63 Million in Financing
Omeros Raises More Than $63 Million in Financing Seattle, WA February 12, 2007 Omeros today announced that it has raised in excess of $63 million in an oversubscribed Series E equity financing. New investors,
More informationW H AT W E D O SPONSORS. Contents INVESTMENT TERMS SENIOR MANAGEMENT
Contents W H AT W E D O 3 SPONSORS 6 INVESTMENT TERMS 7 A D VA N TA G E S 8 SENIOR MANAGEMENT 9 C O N TA C T 10 What we do Typical Real Estate Capital Stack Milestone Partners Real Estate Capital Stack
More information2O2O WOMEN ON BOARDS GENDER DIVERSITY INDEX
2O2O WOMEN ON BOARDS GENDER DIVERSITY INDEX 2018 Progress of Women Corporate Directors by Company Size, State and Industry Sector BOARDROOM DIVERSITY: A STRATEGIC IMPERATIVE WHAT IS THE GENDER DIVERSITY
More informationVenture Capital Report
Venture Capital Report U.S. 4Q 2017 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts
More informationCASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within
More information2013 Global venture capital confidence survey results. How confident are investors?
2013 Global venture capital confidence survey results How confident are investors? August 14, 2013 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing
More informationMergers and Acquisitions/ Private Equity. Providing In-Depth Deal Coverage for Buyers, Sellers, and Investors. Attorney Advertising
Mergers and Acquisitions/ Private Equity Providing In-Depth Deal Coverage for Buyers, Sellers, and Investors Attorney Advertising In every transaction, business perspective informs our legal strategy.
More information2015 Real Estate Industry Update A landscape for change: Transforming for the future
2015 Real Estate Industry Update A landscape for change: Transforming for the future September 17, 2015 Welcome Welcome to Deloitte s 2015 real estate industry update The real estate industry has been
More informationFINC915 Venture Lab Participating Firms: FALL 2010
FINC915 Venture Lab Participating Firms: FALL 2010 Please Note: The listed firms will consider candidates. Not all firms will eventually offer a position to students. LOCAL FIRMS: I2A Fund Number of slots:
More information3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp
3Q13 Trends in Terms of Venture Financings in Silicon Valley Third Quarter 2013 Fenwick fenwick & west llp Silicon Valley Venture Capital Survey Third Quarter 2013 Barry Kramer and Michael Patrick Fenwick
More informationVenture Impact. The Economic Importance of Venture Capital Backed Companies to the U.S. Economy. Third Edition
Venture Impact The Economic Importance of Venture Capital Backed Companies to the U.S. Economy Third Edition ABOUT GLOBAL INSIGHT Global Insight is a privately held company formed from the two most respected
More informationTriton Technology Fund
Triton Technology Fund Presentation to Dean s Engineering Council March 22, 2013 Generate Returns for LPs/GPs Motivation for Fund Catalyze translation of UCSD discoveries for the benefit of society Enable
More information2015 Real Estate Industry Update A landscape for change: Transforming for the future
2015 Real Estate Industry Update A landscape for change: Transforming for the future September 15, 2015 Welcome Welcome to Deloitte s 2015 real estate industry update The real estate industry has been
More informationAre Biotechnology Startups Different?
Are Biotechnology Startups Different? Hervé Lebret Ecole Polytechnique Fédérale de Lausanne Vice-Presidency for Innovation, CH-1015 Lausanne, Switzerland Email: herve.lebret@epfl.ch Phone: +41 21 693 70
More informationPANEL DISCUSSION & ROUNDTABLES
LIFE SCIENCES & HEALTH CARE EVENT Road to commercialization - Challenges, Opportunities & Successes that lie ahead in the Life Sciences and Healthcare Sectors Life Sciences and Healthcare is one of the
More informationJaswinder Jassi S. Chadha
Jaswinder Jassi S. Chadha marketrx Inc Introducing Jaswinder Chadha It is a surprising fact that some of the leading companies arrived at the top without taking early venture capital funding. Today s market
More informationSeptember 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board
AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT
More informationJOHN JACK R. TUPMAN, JR CURRICULUM VITAE
JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant
More informationCVC2.0 Demonstrating Added Value to the Corporate Bottom Line
CVC2.0 Demonstrating Added Value to the Corporate Bottom Line Jaideep Raje Managing Consultant Lux Research June 2, 2016 Agenda CVC1.0 State of the Union So, why change? Reflections on CVC2.0 2 Contents
More informationNJEN: STATE AND FEDERAL RESOURCES FOR ENTREPRENEURS. April 13, 2016
NJEN: STATE AND FEDERAL RESOURCES FOR ENTREPRENEURS April 13, 2016 New Jersey Economic Development Authority Mission The New Jersey Economic Development Authority (EDA) is an independent State agency that
More informationWILSON SONSINI GOODRICH & ROSATI
WILSON SONSINI GOODRICH & ROSATI IS PLEASED TO ANNOUNCE THAT THE FOLLOWING ATTORNEYS HAVE BECOME PARTNERS AT THE FIRM. Troy Foster Corporate & Securities, Palo Alto Jessica L. Margolis Litigation, New
More informationTeresa V. Pahl Partner
Teresa represents clients in all phases and aspects of their businesses. Teresa s expertise includes matters involving general corporate law, securities law and real property law. Teresa works with early-stage
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationHow attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners
How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners How attractive is the BioRegion of Catalonia for foreign investment? M ost
More informationFinancing Growth Ventures to Minimize Equity Dilution
Financing Growth Ventures to Minimize Equity Dilution An entrepreneurial team s mission is to develop and grow its venture and to optimize the management team s equity ownership stake. Significant growth
More informationMoneyTreeTM. Report. Some $171 million VC financing invested in hi-tech companies in Q compared with $255 million in the second quarter 2012
www.pwc.com/il The PwC Israel for the third quarter of 2012 VC investments down 33% from second quarter, lowest investment level in 2012 Some $171 million VC financing invested in hi-tech companies in
More informationVENTURE IMPACT ILLINOIS THE ECONOMIC IMPACT OF VENTURE CAPITAL ON ILLINOIS
VENTURE IMPACT ILLINOIS THE ECONOMIC IMPACT OF VENTURE CAPITAL ON ILLINOIS Executive Summary What Is Venture Capital? Venture Capital Plays an Important Role in the Illinois Economy Venture Capital Investments
More informationThe Danish-American Entrepreneurship Summit
The Danish-American Entrepreneurship Summit Insights Into the US Venture Capital Markets How to Create A Winning Strategy? Clare Fairfield Do Innovation Development Systems Matter? In 2003, venture backed
More informationOUR BELIEFS W H E R E W E A R E F O C U S E D
ABOUT US Formed in 1987, the Gideon Group, Inc. has helped entrepreneurs, project developers and commercial real estate developers raise over $1 billion in startup and expansion capital. We bring a unique
More information2018 Indiana VENTURE REPORT
218 Indiana VENTURE REPORT Content Overview................................ 2 Indiana s Growing Economy................. 3 Indiana s Value for Business................. 3 National Venture Capital Trends..............
More information35 YEARS OF ANALOG INNOVATION 35% NET PROFIT 121 QUARTERS OF POSITIVE CASH FLOW 30 YEARS ON THE NASDAQ 16 YEARS ON THE S&P ANNUAL REPORT
LINEAR TECHNOLOGY CORPORATION 2016 ANNUAL REPORT 16 YEARS ON THE S&P 500 121 QUARTERS OF POSITIVE CASH FLOW 30 YEARS ON THE NASDAQ 35% NET PROFIT 35 YEARS OF ANALOG INNOVATION Financial Highlights 35 Years
More informationTrends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011)
Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011) Background We analyzed the terms of venture financings for 117 companies headquartered in Silicon Valley that reported raising
More information2Q13. Trends in Terms of Venture Financings in Silicon Valley. Second Quarter fenwick & west llp
2Q13 Trends in Terms of Venture Financings in Silicon Valley Second Quarter 2013 Fenwi wick fenwick & west llp Silicon Valley Venture Capital Survey Second Quarter 2013 Barry Kramer and Michael Patrick
More informationGlobal Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner
Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis
More informationSAN DIEGO S QUARTERLY ECONOMIC SNAPSHOT
SAN DIEGO S QUARTERLY ECONOMIC SNAPSHOT August 2017 highlights in THIS ISSUE Every quarter Regional EDC analyzes key economic indicators that are important to understanding the regional economy and the
More information1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp
1h 2012 Trends in Terms of U.S. Life Science Venture Financings First Half 2012 Fenwick fenwick & west llp 1h 2012 Trends in Terms of U.S. Life Science Venture Financings First Half 2012 Survey Introduction
More informationMara H. Rogers, Partner Norton Rose Fulbright
Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers
More informationResults from the 2008 Global Venture Capital Survey. June 2, 2008
Results from the 2008 Global Venture Capital Survey June 2, 2008 Presenters Mark Jensen, Deloitte & Touche LLP Partner and National Director, Venture Capital Services Dixon Doll, DCM Co-Founder and General
More informationRaising capital Healthy fundraising tension shows the market s underlying strength
Innovation Economy Outlook 2015 Raising capital Healthy fundraising tension shows the market s underlying strength Inside > Capital is plentiful, but fundraising remains a challenge. > A tough environment
More informationLynn E. Turner Managing Director
Lynn E. Turner Managing Director 725 South Figueroa Street, Suite 2950 Los Angeles, CA 90017 main: 213.222.0870 fax : 888.222.6001 lturner@litinomics.com Lynn E. Turner is a Managing Director within the
More informationVenture financings in 3Q12 continued to show solid price increases from their prior round, but 3Q12 was not as strong as 2Q12.
Silicon Valley Venture Capital Survey Third Quarter 2012 Barry Kramer and Michael Patrick Fenwick fenwick & west llp Background We analyzed the terms of venture financings for 117 companies headquartered
More informationLife Sciences Outlook. New York City 2016
Life Sciences Outlook City 2016 City is emerging as a leading destination for biotech startups and the larger life sciences industry. Investors have committed millions of dollars throughout the city and
More informationThe View from Silicon Valley
The View from Silicon Valley Future Water Technologies, Markets & Investment Opportunities Developing Future Water Technologies - Membranes Dr. Burton H. Lee PhD MBA Managing Director, Innovarium Ventures
More informationTHE GOLDMAN SACHS GROUP, INC.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event
More informationFUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS
INDUSTRY RE FUNDS 1969 to present Industry surveys, quarterly and annual fund reports 9,240+ venture capital and private equity funds Venture capital and buyout funds that have invested in companies Name
More informationVenture Capital Search Highlights
Venture Capital Venture funding continued at the strongest pace witnessed over the past decade in 2016, and recruiting the future leaders of the industry s emerging growth companies has never been more
More informationConference Speakers. Bo Armstrong, DataPath, Director of Marketing
Conference Speakers Bo Armstrong, DataPath, Director of Marketing Bo Armstrong leads all marketing initiatives for DataPath and its subsidiaries. He joined DataPath in 2015 and has over 15 years of marketing
More informationHFMA January CFO Forum
HFMA January CFO Forum January 26, 2018 St. Mark s Hospital Education Auditorium 1200 E. 3900 S. Salt Lake City, Utah 7.0 CPE hours 7:30 8:00 a.m. Continental Breakfast 8:00 8:15 a.m. Opening and Chapter
More information2015 Real Estate Industry Update A landscape for change: Transforming for the future
2015 Real Estate Industry Update A landscape for change: Transforming for the future December 11, 2015 Welcome Welcome to Deloitte s 2015 real estate industry update The real estate industry has been on
More informationFinancing Emerging Growth Companies
Financing Emerging Growth Companies July (8,15,22) 2005 Ravi Sinha/Wilson Zehr Portland State University School of Business July 8, 2005 1:00 1:50 Class overview, review syllabus, grading, case studies
More information